✦ LIBER ✦

Clinical studies with granisetron, a new 5-HT3 receptor antagonist for the treatment of cancer chemotherapy-induced emesis

✍ Scribed by Joss, Rudolf A.; Dott, Christopher S.

Book ID: 122762974
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 739 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(05)80256-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Batanopride (BMY-25801): A new 5-HT3 rec

Batanopride (BMY-25801): A new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis

✍ Smaldone, L.; Plezia, P.; Alberts, D.; Aapro, M.; Sartiano, G.; Dorn, M.; Brady, 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 608 KB

Treatment of chemotherapy-induced emesis

Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3receptor antagonists

✍ P. J. Hesketh 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 730 KB

Paul J. Hesketh the optimal use of the 5-HT3 antagonists and their integration into clinical practice remain unanswered and are the appropriate focus for additional study.

Tropisetron, a new 5-HT3 receptor antago

Tropisetron, a new 5-HT3 receptor antagonist, in the prevention of radiation-induced emesis

✍ Sorbe, Bengt; Berglind, Anne-Marie; de Bruijn, Karel 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 201 KB

FIRST RESULTS WITH ICS 205-930 (5-HT3 RE

FIRST RESULTS WITH ICS 205-930 (5-HT3 RECEPTOR ANTAGONIST) IN PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS

✍ Leibundgut, U; Lancranjan, I 📂 Article 📅 1987 🏛 The Lancet 🌐 English ⚖ 186 KB

A meta-analysis comparing the efficacy o

A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis

✍ K. Jordan; A. Hinke; A. Grothey; W. Voigt; D. Arnold; H.-H. Wolf; H.-J. Schmoll 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 330 KB

High versus low dose granisetron, a sele

High versus low dose granisetron, a selective 5HT3antagonist, for the prevention of chemotherapy-induced nausea and vomiting

✍ H. C. Falkson; C. I. Falkson; G. Falkson 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 173 KB

Fifty six patients, with histologically confirmed cancer, who received highly emetogenic chemotherapy, were entered on a randomized double blind, low versus high dose, study of granisetron, a 5HT3 receptor antagonist. A single dose of intravenous granisetron protected the majority of patients from n